Clinical evidence and reporting standards in reirradiation: Insights from 28 studies at ESTRO 2025, endorsed by the ESTRO reirradiation focus group
The ESTRO 2025 abstract set illustrates both the clinical potential and methodological variability of modern reRT. While outcomes are promising across several sites, adherence to standardized reporting remains limited, underscoring the need for consistent implementation of ESTRO-EORTC recommendations to enable comparability and harmonization.
Authors
- Stefanie Corradini (ORCID: https://orcid.org/0000-0001-8709-7252)
- Arnaud Beddok (ORCID: https://orcid.org/0000-0002-5512-4161)
- Bartłomiej Tomasik (ORCID: https://orcid.org/0000-0001-5648-345X)
- Eliana Vásquez Osorio (ORCID: https://orcid.org/0000-0003-0741-994X)
- Aileen Duffton (ORCID: https://orcid.org/0000-0003-2413-2561)
- Nicolaus Andratschke (ORCID: https://orcid.org/0000-0003-3647-5916)
- Jonas Willmann (ORCID: https://orcid.org/0000-0002-2531-3551)
- Gian Marco Petrianni (ORCID: https://orcid.org/0000-0002-4678-0116)
- Ane Lindegaard Appelt (ORCID: https://orcid.org/0000-0003-2792-9218)
Institutions
- NHS Greater Glasgow and Clyde (GB)
- Rigshospitalet (DK)
- University of Manchester (GB)
- Universitätsklinikum Erlangen (DE)
- University Hospital of Zurich (CH)
- Campus Bio Medico University Hospital (IT)
- Institut Jean Godinot (FR)
- Gdańsk Medical University (PL)
- Université de Reims Champagne-Ardenne (FR)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1016/j.ctro.2025.101090
- Primary Topic
- Meta-analysis and systematic reviews
- Type
- article
- Field-Weighted Citation Impact
- 0.00